Sintx Technologies (SINT) FCF Margin Growth (5y) (2018 - 2026)
Sintx Technologies (SINT) FCF Margin Growth (5y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 7.23 Mn | 7.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249,412.00 |
| Dec 31, 2025 | 113,069.00 |
| Sep 30, 2025 | 212,679.00 |
| Jun 30, 2025 | -83,164.00 |
| Mar 31, 2025 | 128,313.00 |
| Dec 31, 2024 | 38,552.00 |
| Sep 30, 2024 | 64,345.00 |
| Jun 30, 2024 | 67,879.00 |
| Mar 31, 2024 | 132,840.00 |
| Jun 30, 2023 | -46,702.00 |
| Mar 31, 2023 | -85,117.00 |
| Dec 31, 2022 | -23,843.00 |
| Sep 30, 2022 | -65,513.00 |
| Jun 30, 2022 | -115,599.00 |
| Mar 31, 2022 | -256,258.00 |
| Dec 31, 2021 | -173,548.00 |
| Sep 30, 2021 | -199,788.00 |
| Jun 30, 2021 | -269,086.00 |
| Mar 31, 2021 | -311,017.00 |
| Dec 31, 2020 | -191,043.00 |